成分百科 · CR-49

沒藥醇（Bisabolol）

Bisabolol

閱讀模式

簡明版：使用要點、注意事項與迷思澄清。

簡明衛教

概述

洋甘菊相關抗發炎成分，舒緩配方常見。

適用膚況・有效濃度

依產品標示與耐受逐步建立；嚴重膚況請皮膚科評估。

使用建議

依標示與 patch test；新產品一次導入一種活性。

副作用・禁忌・就醫提醒

若紅腫、滲液、快速惡化應停用人新產品並就醫。

參考文獻與出處

[1]期刊觀察研究
Zhu C; Xia A; Huang Z; Liu C. 2026. A multi-target combinatorial therapy of MDBA alleviates atopic dermatitis via synchronized immunosuppression and barrier repair.. European journal of pharmacology
DOI: 10.1016/j.ejphar.2026.178729PMID: 41802486取用：2026-06-13
[2]期刊觀察研究
Wu Y; Yuan S; Wang Y; Zhang Y. 2025. Exploring the mechanism of α-Bisabolol in the treatment of psoriasis based on network pharmacology and experimental validation.. European journal of pharmacology
DOI: 10.1016/j.ejphar.2025.177433PMID: 40089261取用：2026-06-13
[3]期刊觀察研究
Somboon K; Chng CP; Huang C; Gupta S. 2025. Enhancing Niacinamide Skin Penetration via Other Skin Brightening Agents: A Molecular Dynamics Simulation Study.. International journal of molecular sciences
DOI: 10.3390/ijms26041555PMID: 40004021取用：2026-06-13
[4]期刊觀察研究
Prakoeswa CRS; Damayanti; Anggraeni S; Umborowati MA. 2024. The Role of Moisturizer Containing Anti-inflammatory on Skin Hydration in Mild-Moderate Atopic Dermatitis Patients.. Dermatology research and practice
DOI: 10.1155/drp/3586393PMID: 39741562取用：2026-06-13
[5]期刊觀察研究
Marianni B; Mansourian M; Koulouridas S; Polonini H. 2024. Compatibility of Active Pharmaceutical Ingredients in Cleoderm™: A Comprehensive Study for Enhanced Topical Dermatological Treatments.. International journal of pharmaceutical compounding
PMID: 39405570取用：2026-06-13
[6]期刊觀察研究
Qin Y; Jiang B; Yuan C; Cui L. 2024. Light-emitting diode irradiation at 590 nm combined with active substances modulates ultraviolet B radiation-induced keratinocyte inflammation.. Lasers in medical science
DOI: 10.1007/s10103-024-04178-wPMID: 39223344取用：2026-06-13

本網站內容為一般保養與成分衛教，非醫療診斷或治療建議。化粧品不得宣稱醫療效能；若皮膚問題持續或惡化，請洽皮膚科醫師。

證據等級標示供消費者理解文獻型態，不代表對特定品牌或產品之療效背書；我們不推薦特定醫美療程或處方用藥。